Literature DB >> 19737697

The next generation Endeavor Resolute Stent: role of the BioLinx Polymer System.

Kishore Udipi1, Robert J Melder, Mingfei Chen, Peiwen Cheng, Ayala Hezi-Yamit, Carol Sullivan, Jennifer Wong, Josiah Wilcox.   

Abstract

Year:  2007        PMID： 19737697

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  15 in total

Review 1.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

Review 2.  New drug-eluting stent concepts.

Authors:  Rainer Wessely
Journal:  Nat Rev Cardiol       Date:  2010-03-02       Impact factor: 32.419

3.  Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Authors:  Jung-Sun Kim; Jin-Sun Kim; Dong-Ho Shin; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-21       Impact factor: 2.357

4.  TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives.

Authors:  M W Z Basalus; K Tandjung; K G van Houwelingen; M G Stoel; F H A F de Man; J W Louwerenburg; S A M Saïd; G C M Linssen; M A W J Kleijne; J van der Palen; J Huisman; P M J Verhorst; C von Birgelen
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

5.  Prospective study to evaluate safety and efficacy of Zotarolimus Eluting Stent (PSEZES) in patients with long coronary artery lesions.

Authors:  C G Bahuleyan; V V Krishna Kumar; Shifas Babu
Journal:  Indian Heart J       Date:  2015-05-13

6.  [New developments in drug-eluting stents].

Authors:  M Kollum; C Bode
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

7.  Location-dependent coronary artery diffusive and convective mass transport properties of a lipophilic drug surrogate measured using nonlinear microscopy.

Authors:  Joseph T Keyes; Bruce R Simon; Jonathan P Vande Geest
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

Review 8.  Novel drug-eluting stents in the treatment of de novo coronary lesions.

Authors:  Davide Capodanno; Fabio Dipasqua; Corrado Tamburino
Journal:  Vasc Health Risk Manag       Date:  2011-02-25

9.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

Authors:  Juan Luis Gutiérrez-Chico; Robert Jan van Geuns; Evelyn Regar; Willem J van der Giessen; Henning Kelbæk; Kari Saunamäki; Javier Escaned; Nieves Gonzalo; Carlo di Mario; Francesco Borgia; Eveline Nüesch; Héctor M García-García; Sigmund Silber; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-06-09       Impact factor: 29.983

10.  Advances in drug eluting stents - focus on the Endeavor(®) zotarolimus stent.

Authors:  Jonathan Bridges; Donald Cutlip
Journal:  Med Devices (Auckl)       Date:  2008-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.